Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention

D G Bostwick1, R Neumann, J Qian

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn. 55905, USA. bostwick.david@mayo.edu

European Urology
|May 15, 1999
PubMed